These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 14827945)
21. Control of ethyl biscoumacetate (tromexan) therapy by standardized clotting time of whole blood. MAYER GA; CONNELL WF Can Med Assoc J; 1957 Nov; 77(10):930-8. PubMed ID: 13479846 [No Abstract] [Full Text] [Related]
22. [Effect of tromexan and dicumarol on clotting time and prothrombin index]. KRISTENSON A Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696 [No Abstract] [Full Text] [Related]
23. [Metabolism in rats following prolonged administration of pelentan (di 4-hydroxycumarinyl-3-acetic acid ethylester); studies on anticoagulant substances V]. HAIS IM; ZABRODSKY S Cas Lek Cesk; 1950 Oct; 89(40):1116-20. PubMed ID: 14772872 [No Abstract] [Full Text] [Related]
24. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)]. PUNDEL JP Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529 [No Abstract] [Full Text] [Related]
25. Mode of action of tromexan. HUNTER RB; TUDHOPE GR Lancet; 1953 Apr; 1(6765):821-3. PubMed ID: 13036185 [No Abstract] [Full Text] [Related]
26. The treatment of coronary thrombosis and fresh myocardial infarction with a new anticoagulant tromexan. von HUEBER EF Cardiologia (Basel); 1950; 17(3-4):223-33. PubMed ID: 14801796 [No Abstract] [Full Text] [Related]
27. [New indications for anticoagulant therapy of coronary diseases]. ASKANAS Z Pol Tyg Lek (Wars); 1950 Nov; 5(47-48):1652-3. PubMed ID: 14816125 [No Abstract] [Full Text] [Related]
30. [ON EXPERIENCES WITH ANTICOAGULANT THERAPY IN MYOCARDIAL INFARCT]. ANDERS G; SCHROETER RM; HEINE H Dtsch Gesundheitsw; 1964 Jan; 19():81-5. PubMed ID: 14181393 [No Abstract] [Full Text] [Related]
31. [Prophylaxis of thrombosis with tromexan in closed fractures of the leg]. GLOOR F; SIGG B Praxis; 1950 Sep; 39(39):839-40. PubMed ID: 14786168 [No Abstract] [Full Text] [Related]
32. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT. POLLER L Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255 [No Abstract] [Full Text] [Related]
33. [About Tromexan Prophylaxis]. LUDWIG F Gynaecologia; 1956 Nov; 142(5):330. PubMed ID: 13397884 [No Abstract] [Full Text] [Related]
34. ANTICOAGULANT ACTIVITY OF ACENOCOUMARIN IN EXPERIMENTAL ANIMALS. JINDAL MN; SHAH DS Indian J Physiol Pharmacol; 1964 Jan; 8():72-9. PubMed ID: 14248536 [No Abstract] [Full Text] [Related]
35. [Therapy of complicated pulmonary infarcts with anticoagulants (tromexan); radiographic proof]. DONNER M Med Klin; 1952 Jul; 47(30):995-7. PubMed ID: 12992452 [No Abstract] [Full Text] [Related]
36. [REPORT ON EXPERIENCES WITH A 6-YEAR CONTINUOUS ANTICOAGULANT TREATMENT]. TVERDY E Wien Z Inn Med; 1964 Feb; 45():55-7. PubMed ID: 14155961 [No Abstract] [Full Text] [Related]
37. [Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid]. BELLER FK Z Geburtshilfe Gynakol; 1954; 141(2):194-223. PubMed ID: 13227050 [No Abstract] [Full Text] [Related]
38. [Prolonged treatment of peripheral arterial diseases with Tromexan]. LANFRANCHI W; DEGNI M Arq Bras Med; 1960; 50():499-502. PubMed ID: 14462031 [No Abstract] [Full Text] [Related]
39. [Use of anticoagulants in dermatology; use of tromexan (ethyl ester of di-4-hydroxy-coumarinyl acetic acid) in ulcus cruris in dystrophy with thrombophlebitis and in related conditions]. PANCONESI E Rass Dermatol Sifilogr; 1951; 4(2):74-105. PubMed ID: 14892261 [No Abstract] [Full Text] [Related]